JPRN-UMIN000025716Unknown未知
A feasible study for measurement of lipid mediator in exhaled breath condensate of the chronic cough patients and healthy subjects - A feasible study for measurement of lipid mediator in exhaled breath condensate of the chronic cough patients and healthy subjects
Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University0 sites110 target enrollmentStarted: January 18, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Sponsor
- Enrollment
- 110
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Key exclusion criteria were: use of histamin H1 receptor antagonist, inhaled/oral/intravenous corticosteroid, leukotriene receptor antagonist, beta2-aganist, theophylline, macroraide, expectorant drug, and proton pump inhibitor; women of childbearing potential or of breast-feeding; mental disorder or psychiatric symptom; several medical conditions prohibiting partitipation
Investigators
Similar Trials
Completed
Not Applicable
Clinical study to investigate lipid modifying effects of hydroxytyrosol – a randomized, double-blind, placebo-controlled parallel studyHealthy subjects with slight to moderately elevated LDL-cholesterol level.DRKS00015251Wacker Chemie AG92
Completed
Not Applicable
Clinical study to investigate lipid-modifying effects of a Saskatoon berry extract - a randomized, double-blind, placebo-controlled parallel studyHealthy subjectsDRKS00015503Prairie Berries Europe GmbH50
Completed
Not Applicable
ipid mediators of ultraviolet radiation (UVR) induced skin inflammatioTopic: SkinSubtopic: Skin (all Subtopics)Disease: DermatologySkin and Connective Tissue DiseasesAcute skin changes due to ultraviolet radiationISRCTN47896115niversity of Manchester125
Active, not recruiting
Not Applicable
A pilot, randomized trial to evaluate the lipid profile after antiretroviral regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals - STAR2immunodefic syndrome - patients naive antiretroviral therapyMedDRA version: 9.1Level: LLTClassification code 10000565Term: Acquired immunodeficiency syndromeEUCTR2007-007882-19-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Completed
Not Applicable
Performance evaluation of noninvasive lipid measurement device by fat load testJPRN-UMIN000027559Hokkaido Information University24